Chronic Spontaneous Urticaria Learning Hub

Welcome to the CSU learning hub focused on key scientific education on chronic spontaneous urticaria, featuring ADVENT resources.

Chronic spontaneous urticaria (CSU) is a chronic inflammatory disease characterized by wheals, angioedema, or both, that recur for more than 6 weeks without an identifiable trigger. View the resources below to learn about a variety of topics related to CSU.
 

Pathophysiology of CSU

Explore the pathophysiology of CSU including the role of type 2 inflammation.

How type 2 cytokines can amplify inflammatory response in CSU
Dermatology
expert video

How type 2 cytokines can amplify inflammatory response in CSU

Chronic Spontaneous Urticaria Mechanism of Disease Animation
Dermatology
videoanimation

Chronic Spontaneous Urticaria Mechanism of Disease Animation

Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
Dermatology
expert video

Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Clinical Presentation, Diagnosis, and Burden of CSU

Understand the clinical presentation, diagnostic process and burden of CSU.

CSU is Associated With a High Burden and Impact on Quality of Life
Dermatology
expert video

CSU is Associated With a High Burden and Impact on Quality of Life

Test your knowledge

Check your understanding of the latest clinical insights and disease management.
MAT-GLB-2506644 - 1.0 - 11/2025

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region